|
Woulfe, S L; Bono, C P; Zacheis, M L et al. (1997) A peptidomimetic that specifically inhibits human leukocyte antigen DRB1*0401-restricted T cell proliferation. J Pharmacol Exp Ther 281:663-9
|
|
Woulfe, S L; Bono, C P; Zacheis, M L et al. (1995) Negatively charged residues interacting with the p4 pocket confer binding specificity to DRB1*0401. Arthritis Rheum 38:1744-53
|
|
Fu, X T; Bono, C P; Woulfe, S L et al. (1995) Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide. J Exp Med 181:915-26
|
|
Kirschmann, D A; Duffin, K L; Smith, C E et al. (1995) Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles. J Immunol 155:5655-62
|
|
Nygard, N R; Giacoletto, K S; Bono, C et al. (1994) Peptide binding to surface class II molecules is the major pathway of formation of immunogenic class II-peptide complexes for viable antigen presenting cells. J Immunol 152:1082-93
|
|
Nygard, N R; Schwartz, B D (1993) Infection and autoimmunity. Adv Intern Med 38:337-59
|
